A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
Clinical trial NCT04914741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04914741
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2023-12-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.